Awfis Space Solutions Limited has completed the execution of loan documentation with ICICI Bank Limited on February 25, 2026, marking the finalization of credit facility arrangements between the two entities. The company has duly informed both the National Stock Exchange of India Limited and BSE Limited about this development through regulatory filings.

Regulatory Compliance and Documentation

The loan documentation execution has been disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's filing references SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, ensuring adherence to updated regulatory guidelines.

Previous Intimations and Timeline

The current documentation execution follows a series of regulatory intimations provided by Awfis Space Solutions Limited to the stock exchanges. The company had previously informed the exchanges about the proposed credit facilities through intimations dated November 11, 2025 and February 02, 2026. These earlier communications contained the relevant information required under SEBI LODR Regulations regarding the proposed banking arrangements.

Corporate Communication Details

The regulatory filing was signed by Shweta Gupta, Company Secretary and Compliance Officer, bearing membership number F8573. The digital signature was applied on February 25, 2026 at 10:53:36 +05'30', confirming the authenticity of the disclosure. The company has also made this information available on its investor relations website for stakeholder access.

Company Information

Awfis Space Solutions Limited operates from its corporate and registered office located at C-28-29, Kissan Bhawan, Qutab Institutional Area, New Delhi – 110016. The company, incorporated with CIN L74999DL2014PLC274236, maintains its investor communications through established channels and continues to ensure regulatory compliance across all material developments.

Awfis Space Solutions Limited has completed the allotment of 31,450 equity shares to eligible employees under its Employee and Director Stock Options Scheme 2015 (EDSOP 2015). The Nomination and Remuneration Committee approved this allotment through a resolution passed by circulation on February 09, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Allotment Details

The allotted shares carry a face value of Rs. 10 each and were issued to employees who exercised their vested stock options under the EDSOP 2015 scheme. The exercise of these options generated total proceeds of Rs. 44,65,800.00 for the company.

Exercise Price Structure

The shares were allotted at two different exercise price levels, reflecting the varying grant dates and market conditions when the options were originally issued to employees.

Impact on Share Capital

Following this allotment, the company's paid-up share capital has increased substantially. The total number of outstanding equity shares has grown, reflecting the dilutive effect of the employee stock option exercise.

ESOP Scheme Status

Under the EDSOP 2015 scheme, 2,02,703 options remain vested as of the reporting date, excluding the total shares exercised till date. The scheme allows employees a 15-year exercise period from their respective vesting dates. Out of the total 23,76,866 options for which in-principal approvals were obtained from NSE and BSE, 41,140 options have lapsed.

The diluted earnings per share stands at Rs. 9.34 as of March 31, 2025. All newly allotted equity shares rank pari passu with existing equity shares of the company, carrying identical voting rights and dividend entitlements.